Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05228691 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevalence of Long COVID-19 in the Canary Islands

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 28, 2025 (before its estimated December 22, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion date: Sep 22, 2025 to Dec 22, 2025
    • Study completion date: Dec 1, 2025 to May 1, 2026
    • Site contact updated
    • Publications: details revised at 4 of 4 entries
    v13
  2. Notable Primary completion date: Sep 22, 2024 to Sep 22, 2025
    • Study completion date: Dec 1, 2024 to Dec 1, 2025
    • Site contact updated
    • Publications: details revised at 4 of 4 entries
    v12
  3. Minor Primary completion date: Apr 22, 2024 to Sep 22, 2024v11
  4. Minor Primary completion date: Dec 22, 2023 to Apr 22, 2024
    • Study completion date: Jun 1, 2024 to Dec 1, 2024
    v10
  5. Minor Primary completion date: Oct 22, 2023 to Dec 22, 2023v9
Show 7 earlier versionsHide 7 earlier versions
  1. Minor Primary completion date: May 22, 2023 to Oct 22, 2023
    • Study completion date: Sep 1, 2023 to Jun 1, 2024
    v8
  2. Minor Primary completion date: Dec 22, 2022 to May 22, 2023
    • Study completion date: Apr 1, 2023 to Sep 1, 2023
    v7
  3. Minor Primary completion date: Oct 22, 2022 to Dec 22, 2022v6
  4. Minor Primary completion date: Jun 22, 2022 to Oct 22, 2022
    • Study completion date: Dec 1, 2022 to Apr 1, 2023
    v5
  5. Minor Re-verified, no change to tracked fieldsv4
  6. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Apr 1, 2022 to Jun 22, 2022
    • Start date: Mar 1, 2022 to Mar 22, 2022
    • Site details revised
    v3
  7. Minor Secondary endpoints: details revised at 4 of 5 entries
    • Study description expanded, about 8 words
    • Study title revised
    • Eligibility criteria shortened, about 1 word
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
With more than 246 million people diagnosed with coronavirus 2019 (COVID-19) around the world, many of whom have required medical attention for past 23 months, greater emphasis is being placed on post-acute care of COVID-19 survivors. According to recent data, millions of patients who have recovered from acute COVID-19 are experiencing persistent symptoms, which lead to disability and impaired activities of daily living. Various terms have been used to describe the condition of patients who do not return to their initial health status to include post-acute sequelae of COVID-19, such as post-acute COVID syndrome (PACS) and Long COVID. The growing global burden of COVID-19 suggests that the potential effects of Long COVID in public health are vast even if Long COVID is experienced by a small proportion of patients recovering from acute infection. The ability to identify patients at high risk for Long COVID and forecasting medical resource requirements is of important clinical utility in the present. In view of the large number of people surviving after infection with COVID-19 and that should require follow-up, determine which patients are at risk of have Long COVID and who require close monitoring is crucial. In this study, therefore, we set out to analyze what type of patient profile with COVID-19 who, after 12 weeks of having suffered the infection, experiences the signs and symptoms described by current literature.
Trial Details
NCT Number NCT05228691
Lead Sponsor University of Las Palmas de Gran Canaria
Conditions
(from sponsor)
COVID-19
Related terms COVID-19, Post-Acute COVID-19 Syndrome
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov